Biggest changeYear Ended June 30 % Change % Change in Constant Currency ($ in millions, except per share data) 2024 2023 Variance Net sales, as reported $ 15,608 $ 15,910 $ (302) (2) % (1) % Returns associated with restructuring and other activities 1 27 (26) Net sales, as adjusted $ 15,609 $ 15,937 $ (328) (2) % (1) % Operating income, as reported $ 970 $ 1,509 $ (539) (36) % (34) % Charges associated with restructuring and other activities 124 85 39 Goodwill and other intangible asset impairments 471 207 264 Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax 23 22 1 Operating income, as adjusted $ 1,588 $ 1,823 $ (235) (13) % (10) % Diluted net earnings per common share, as reported $ 1.08 $ 2.79 $ (1.71) (61) % (60) % Charges associated with restructuring and other activities .27 .18 .09 Goodwill and other intangible asset impairments 1.19 .44 .75 Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax (less portion attributable to redeemable noncontrolling interest) .05 .05 — Diluted net earnings per common share, as adjusted $ 2.59 $ 3.46 $ (.87) (25) % (22) % As diluted net earnings per common share, as adjusted, is used as a measure of the Company’s performance, we consider the impact of current and deferred income taxes when calculating the per-share impact of each of the reconciling items. 46 Table of Contents The following table reconciles the change in net sales by product category and geographic region, as reported, to the change in net sales excluding the effects of foreign currency translation: As Reported Year Ended June 30 ($ in millions) 2024 2023 Variance Impact of foreign currency translation Variance, in constant currency % Change, as reported % Change, in constant currency By Product Category: Skin Care $ 7,908 $ 8,249 $ (341) $ 79 $ (262) (4) % (3) % Makeup 4,470 4,532 (62) 14 (48) (1) (1) Fragrance 2,487 2,451 36 12 48 1 2 Hair Care 629 652 (23) — (23) (4) (4) Other 115 53 62 — 62 100+ 100+ 15,609 15,937 (328) 105 (223) (2) (1) Returns associated with restructuring and other activities (1) (27) 26 — 26 Total $ 15,608 $ 15,910 $ (302) $ 105 $ (197) (2) % (1) % By Region: The Americas $ 4,581 $ 4,518 $ 63 $ 4 $ 67 1 % 1 % Europe, the Middle East & Africa 6,140 6,225 (85) (54) (139) (1) (2) Asia/Pacific 4,888 5,194 (306) 155 (151) (6) (3) 15,609 15,937 (328) 105 (223) (2) (1) Returns associated with restructuring and other activities (1) (27) 26 — 26 Total $ 15,608 $ 15,910 $ (302) $ 105 $ (197) (2) % (1) % 47 Table of Contents The following tables reconcile the change in operating results by product category and geographic region, as reported, to the change in operating income excluding the impact of goodwill and other intangible asset impairments and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax: As Reported Add: Changes in Goodwill and other intangible asset impairments Add: Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax Variance, as adjusted % Change, as reported % Change, as adjusted Year Ended June 30 ($ in millions) 2024 2023 Variance By Product Category: Skin Care $ 735 $ 1,277 $ (542) $ 371 $ 1 $ (170) (42)% (12)% Makeup 93 (21) 114 (107) — 7 100+ 8 Fragrance 265 370 (105) — — (105) (28) (28) Hair Care (52) (36) (16) — — (16) (44) (44) Other 53 4 49 — — 49 100+ 100+ 1,094 1,594 $ (500) $ 264 $ 1 $ (235) (31)% (13)% Charges associated with restructuring and other activities (124) (85) Total $ 970 $ 1,509 By Region: The Americas $ 34 $ (73) $ 107 $ (107) $ (8) $ (8) 100+% (14)% Europe, the Middle East & Africa 836 843 (7) — 9 2 (1) — Asia/Pacific 224 824 (600) 371 — (229) (73) (25) 1,094 1,594 $ (500) $ 264 $ 1 $ (235) (31)% (13)% Charges associated with restructuring and other activities (124) (85) Total $ 970 $ 1,509 48 Table of Contents FINANCIAL CONDITION LIQUIDITY AND CAPITAL RESOURCES Overview Our principal sources of funds historically have been cash flows from operations, borrowings pursuant to our commercial paper program, borrowings from the issuance of long-term debt and committed and uncommitted credit lines provided by banks and other lenders in the United States and abroad.
Biggest changeGAAP measures. 47 Table of Contents Year Ended June 30, % Change % Change in Constant Currency ($ in millions, except per share data) 2025 2024 Variance Net sales, as reported $ 14,326 $ 15,608 $ (1,282) (8) % (8) % Returns associated with restructuring and other activities (3) 1 (4) Net sales, as adjusted $ 14,323 $ 15,609 $ (1,286) (8) % (8) % Operating (loss) income, as reported $ (785) $ 970 $ (1,755) (100+)% (100+)% Charges associated with restructuring and other activities 486 124 362 Goodwill impairment 13 291 (278) Impairment of other intangible assets 1,273 180 1,093 Talcum litigation settlement agreements 159 — 159 Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax — 23 (23) Operating income, as adjusted $ 1,146 $ 1,588 $ (442) (28) % (27) % Provision for income taxes, as reported $ 93 $ 363 $ (270) (74) % (73) % Effective rate for income taxes, as reported (8.9) % 47.0 % Charges associated with restructuring and other activities 105 27 78 Goodwill and other intangible asset impairments 285 41 244 U.S. deferred tax asset valuation allowance adjustment (172) — (172) Talcum litigation settlement agreements 35 — 35 Provision for income taxes, as adjusted $ 346 $ 431 $ (85) (20) % (19) % Effective rate for income taxes, as adjusted 38.8 % 31.0 % Diluted net (loss) earnings per common share, as reported $ (3.15) $ 1.08 $ (4.23) (100+)% (100+)% Charges associated with restructuring and other activities 1.06 .27 .79 Goodwill and other intangible asset impairments 2.78 1.19 1.59 U.S. deferred tax asset valuation allowance adjustment .48 — .48 Talcum litigation settlement agreements .34 — .34 Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax (less portion attributable to redeemable noncontrolling interest) — .05 (.05) Diluted net earnings per common share, as adjusted $ 1.51 $ 2.59 $ (1.08) (42) % (41) % As diluted net earnings per common share, as adjusted, is used as a measure of the Company’s performance, we consider the impact of current and deferred income taxes when calculating the per-share impact of each of the reconciling items. 48 Table of Contents The following table reconciles the change in net sales by product category and geographic region, as reported, to the change in net sales excluding the effects of foreign currency translation: As Reported Year Ended June 30, ($ in millions) 2025 2024 Variance Impact of foreign currency translation Variance, in constant currency % Change, as reported % Change, in constant currency By Product Category: Skin Care $ 6,962 $ 7,908 $ (946) $ 2 $ (944) (12) % (12) % Makeup 4,205 4,470 (265) 20 (245) (6) (5) Fragrance 2,491 2,487 4 4 8 — — Hair Care 565 629 (64) 2 (62) (10) (10) Other 100 115 (15) — (15) (13) (13) 14,323 15,609 (1,286) 28 (1,258) (8) (8) Returns associated with restructuring and other activities 3 (1) 4 — 4 Total $ 14,326 $ 15,608 $ (1,282) $ 28 $ (1,254) (8) % (8) % By Geographic Region: The Americas $ 4,411 $ 4,581 $ (170) $ 50 $ (120) (4) % (3) % Europe, the Middle East & Africa 5,375 6,140 (765) (27) (792) (12) (13) Asia/Pacific 4,537 4,888 (351) 5 (346) (7) (7) 14,323 15,609 (1,286) 28 (1,258) (8) (8) Returns associated with restructuring and other activities 3 (1) 4 — 4 Total $ 14,326 $ 15,608 $ (1,282) $ 28 $ (1,254) (8) % (8) % 49 Table of Contents The following table reconciles the change in operating results by product category and geographic region, as reported, to the change in operating results excluding the impact of goodwill and other intangible asset impairments, talcum litigation settlement agreements and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax: As Reported Add: Changes in goodwill and other intangible asset impairments Add: Talcum litigation settlement agreements Add: Change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax Variance, as adjusted % Change, as reported % Change, as adjusted Year Ended June 30, ($ in millions) 2025 2024 Variance By Product Category: Skin Care $ 574 $ 735 $ (161) $ (96) $ — $ (23) $ (280) (22)% (23)% Makeup (441) 93 (534) 308 159 — (67) (100+) (72) Fragrance (378) 265 (643) 549 — — (94) (100+) (35) Hair Care (41) (52) 11 — — — 11 21 21 Other (13) 53 (66) 54 — — (12) (100+) (23) (299) 1,094 $ (1,393) $ 815 $ 159 $ (23) $ (442) (100+)% (28)% Charges associated with restructuring and other activities (486) (124) Total $ (785) $ 970 By Geographic Region: The Americas $ (918) $ 34 $ (952) $ 911 $ 159 $ (14) $ 104 (100+)% 100+% Europe, the Middle East & Africa 610 836 (226) — (9) (235) (27) (28) Asia/Pacific 9 224 (215) (96) — — (311) (96) (45) (299) 1,094 $ (1,393) $ 815 $ 159 $ (23) $ (442) (100+)% (28)% Charges associated with restructuring and other activities (486) (124) Total $ (785) $ 970 50 Table of Contents FINANCIAL CONDITION LIQUIDITY AND CAPITAL RESOURCES Overview Our principal sources of funds historically have been cash flows from operations, borrowings pursuant to our commercial paper program, borrowings from the issuance of long-term debt and committed and uncommitted credit lines provided by banks and other lenders in the United States and abroad.
The following tables provide reconciliations between these non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
The following tables provide reconciliations between these non-GAAP financial measures and the most directly comparable U.S.
We considered macroeconomic factors including the global economic growth, general macroeconomic trends for the markets in which the reporting units operate and the intangible assets are employed, and the growth of the global prestige beauty industry.
We considered macroeconomic factors including global economic growth, general macroeconomic trends for the markets in which the reporting units operate and the intangible assets are employed, and the growth of the global prestige beauty industry.
Financial Statements and Supplementary Data – Note 2 – Summary of Significant Accounting Policies , Note 6 – Goodwill and Other Intangible Assets . Income Taxes We calculate and provide for income taxes in each tax jurisdiction in which we operate.
Financial Statements and Supplementary Data – Note 2 – Summary of Significant Accounting Policies and Note 6 – Goodwill and Other Intangible Assets . Income Taxes We calculate and provide for income taxes in each tax jurisdiction in which we operate.
Factors that could cause actual results to differ from expectations include, without limitation: (1) increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses; (2) our ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in our business; (3) consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell our products, an increase in the ownership concentration within the retail industry, ownership of retailers by our competitors or ownership of competitors by our customers that are retailers and our inability to collect receivables; (4) destocking and tighter working capital management by retailers; 53 Table of Contents (5) the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs; (6) shifts in the preferences of consumers as to where and how they shop; (7) social, political and economic risks to our foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States; (8) changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, our business, including those relating to our products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result; (9) foreign currency fluctuations affecting our results of operations and the value of our foreign assets, the relative prices at which we and our foreign competitors sell products in the same markets and our operating and manufacturing costs outside of the United States; (10) changes in global or local conditions, including those due to volatility in the global credit and equity markets, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase our products while traveling, the financial strength of our customers, suppliers or other contract counterparties, our operations, the cost and availability of capital which we may need for new equipment, facilities or acquisitions, the returns that we are able to generate on our pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying our critical accounting estimates; (11) shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture our products or at our distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings; (12) real estate rates and availability, which may affect our ability to increase or maintain the number of retail locations at which we sell our products and the costs associated with our other facilities; (13) changes in product mix to products which are less profitable; (14) our ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within our cost estimates; to maintain continuous operations of our new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media; (15) our ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom; (16) consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation; (17) the timing and impact of acquisitions, investments and divestitures; and (18) additional factors as described in our filings with the Securities and Exchange Commission, including this Annual Report on Form 10-K for the fiscal year ended June 30, 2024.
Factors that could cause actual results to differ from expectations include, without limitation: (1) increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses; (2) our ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in our business; (3) consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell our products, an increase in the ownership concentration within the retail industry, ownership of retailers by our competitors or ownership of competitors by our customers that are retailers and our inability to collect receivables; (4) destocking and tighter working capital management by retailers; (5) the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs; (6) shifts in the preferences of consumers as to how they perceive value and where and how they shop; (7) social, political and economic risks to our foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States; (8) changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, our business, including those relating to our products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result; (9) foreign currency fluctuations affecting our results of operations and the value of our foreign assets, the relative prices at which we and our foreign competitors sell products in the same markets and our operating and manufacturing costs outside of the United States; (10) changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase our products while traveling, the financial strength of our customers, suppliers or other contract counterparties, our operations, the cost and availability of capital which we may need for new equipment, facilities or acquisitions, the returns that we are able to generate on our pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying our critical accounting estimates; (11) shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture our products or at our distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings; 56 Table of Contents (12) real estate rates and availability, which may affect our ability to increase or maintain the number of retail locations at which we sell our products and the costs associated with our other facilities; (13) changes in product mix to products which are less profitable; (14) our ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within our cost estimates; to maintain continuous operations of our new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media; (15) our ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom; (16) consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation; (17) the timing and impact of acquisitions, investments and divestitures; and (18) additional factors as described in our filings with the Securities and Exchange Commission, including this Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Under the market approach, we utilized market multiples from publicly traded companies with similar operating and investment characteristics as the reporting unit. The significant assumptions used in these two approaches include revenue growth rates and profit margins, terminal value, the weighted average cost of capital used to discount future cash flows and comparable market multiples.
Under the market approach, we utilized market multiples from publicly traded companies with similar operating and investment characteristics as the reporting unit. The significant assumptions used in these two approaches include revenue growth rates and profit margins, terminal value, weighted average cost of capital used to discount future cash flows and comparable market multiples for the reporting unit.
When testing goodwill for impairment, we have the option of first performing a qualitative assessment to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.
When testing goodwill for impairment, we have the option of first performing a qualitative assessment to determine whether it is more-likely-than-not that the estimated fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test.
Under the income approach, we determined fair value using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflected the relative risk of the cash flows.
Under the income approach, we determined the estimated fair value using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflected the relative risk of the cash flows.
The quantitative impairment test for other indefinite-lived intangible assets encompasses calculating the fair value of an other indefinite-lived intangible asset and comparing the fair value to its carrying value. If the carrying value exceeds the fair value, an impairment charge is recorded.
The quantitative impairment test for other indefinite-lived intangible assets encompasses calculating the estimated fair value of an other indefinite-lived intangible asset and comparing the estimated fair value to its carrying value. If the carrying value exceeds the estimated fair value, an impairment charge is recorded.
Inflation impacted our operating results during fiscal 2024 and we expect it to continue. Generally, we have plans to introduce new products at higher prices, increase prices and implement other operating efficiencies which we expect to offset some of these cost increases. Credit Ratings Changes in our credit ratings will likely result in changes in our borrowing costs.
Inflation impacted our operating results during fiscal 2025 and we expect it to continue. Generally, we have plans to introduce new products at higher prices, increase prices and implement other operating efficiencies which we expect to offset some of these cost increases. Credit Ratings Changes in our credit ratings will likely result in changes in our borrowing costs.
Qualified Plan, we maintain an investment strategy of matching the duration of a substantial portion of the plan assets with the duration of the underlying plan liabilities. This strategy assists us in maintaining our overall funded ratio. For fiscal 2024 and 2023, we met or exceeded all contribution requirements under ERISA regulations for the U.S. Qualified Plan.
Qualified Plan, we maintain an investment strategy of matching the duration of a substantial portion of the plan assets with the duration of the underlying plan liabilities. This strategy assists us in maintaining our overall funded ratio. For fiscal 2025 and 2024, we met or exceeded all contribution requirements under ERISA regulations for the U.S. Qualified Plan.
Although the outcome relating to these exposures is uncertain, in our opinion adequate provisions for income taxes have been made for estimable potential liabilities emanating from these exposures. If actual outcomes differ materially from these estimates, they could have a material impact on our consolidated net earnings. For further discussion of Income Taxes, see Item 8.
Although the outcome relating to these exposures is uncertain, in our opinion adequate provisions for income taxes have been made for estimable potential liabilities emanating from these exposures. If actual outcomes differ materially from these estimates, they could have a material impact on our consolidated net earnings. 55 Table of Contents For further discussion of Income Taxes, see Item 8.
See Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Financial Condition of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 for the fiscal 2023 to fiscal 2022 comparative discussions.
See Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Financial Condition of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 for the fiscal 2024 to fiscal 2023 comparative discussions.
Financial Statements and Supplementary Data – Note 2 – Summary of Significant Accounting Policies for discussion regarding the impact of accounting standards that were recently issued but not yet effective, on our consolidated financial statements. 51 Table of Contents CRITICAL ACCOUNTING POLICIES AND ESTIMATES The discussion and analysis of our financial condition at June 30, 2024 and our results of operations for the three fiscal years ended June 30, 2024 are based upon our consolidated financial statements, which have been prepared in conformity with U.S. generally accepted accounting principles (“U.S.
Financial Statements and Supplementary Data – Note 2 – Summary of Significant Accounting Policies for discussion regarding the impact of accounting standards that were recently issued but not yet effective, on our consolidated financial statements. 53 Table of Contents CRITICAL ACCOUNTING POLICIES AND ESTIMATES The discussion and analysis of our financial condition at June 30, 2025 and our results of operations for the three fiscal years ended June 30, 2025 are based upon our consolidated financial statements, which have been prepared in conformity with U.S. generally accepted accounting principles (“U.S.
Our credit ratings also impact the cost of our revolving credit facility. Downgrades in our credit ratings may reduce our ability to issue commercial paper and/or long-term debt and would likely increase the relative costs of borrowing.
Our credit ratings also impact the cost of our revolving credit facilities. Downgrades in our credit ratings may reduce our ability to issue commercial paper and/or long-term debt and would likely increase the relative costs of borrowing.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Operations of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2023 for the fiscal 2023 to fiscal 2022 comparative discussion.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Operations of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 for the fiscal 2024 to fiscal 2023 comparative discussion.
GAAP measures. 45 Table of Contents RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business.
GAAP measures. 46 Table of Contents RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business.
Our effective tax rate will change from year-to-year based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, tax reserve adjustments, the tax impact of stock-based compensation, the interaction of various global tax strategies and the impact from certain acquisitions.
Our effective tax rate will change from year to year based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, tax reserve adjustments, the tax impact of stock-based compensation, changes to valuation allowance, the interaction of various global tax strategies and the impact from certain acquisitions.
A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our portfolio would have resulted in a net decrease in the fair value of our portfolio of approximately $371 million and $265 million as of June 30, 2024 and 2023, respectively. This potential change does not consider our underlying foreign currency exposures.
A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our portfolio would have resulted in a net decrease in the fair value of our portfolio of approximately $223 million and $371 million as of June 30, 2025 and 2024, respectively. This potential change does not consider our underlying foreign currency exposures.
Financial Statements and Supplementary Data – Note 17 – Commitments and Contingencies . 50 Table of Contents Contractual Obligations For a discussion of our contractual obligations, see Item 8. Financial Statements and Supplementary Data – Note 17 – Commitments and Contingencies (Contractual Obligations) .
Financial Statements and Supplementary Data – Note 17 – Commitments and Contingencies . 52 Table of Contents Contractual Obligations For a discussion of our contractual obligations, see Item 8. Financial Statements and Supplementary Data – Note 17 – Commitments and Contingencies (Contractual Obligations) .
A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our cross-currency swap contracts would have resulted in a net decrease in the fair value of our cross-currency swap contracts of approximately $49 million as of June 30, 2024 and 2023.
A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our cross-currency swap contracts would have resulted in a net decrease in the fair value of our cross-currency swap contracts of approximately $85 million and $49 million as of June 30, 2025 and 2024, respectively.
Dividends For a summary of quarterly cash dividends declared per share on our Class A and Class B Common Stock during the year ended June 30, 2024 and through August 16, 2024, see Item 8. Financial Statements and Supplementary Data – Note 18 – Common Stock .
Dividends For a summary of quarterly cash dividends declared per share on our Class A and Class B Common Stock during the year ended June 30, 2025 and through August 13, 2025, see Item 8. Financial Statements and Supplementary Data – Note 18 – Common Stock .
Returns associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed a Company-wide initiative to redesign, resize and reorganize select areas of the business.
Charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
Based on a hypothetical 100 basis point increase in interest rates, the estimated fair value of our interest rate derivatives would decrease by approximately $48 million and $55 million as of June 30, 2024 and 2023, respectively.
Based on a hypothetical 100 basis point increase in interest rates, the estimated fair value of our interest rate derivatives would decrease by approximately $43 million and $48 million as of June 30, 2025 and 2024, respectively.
The following table summarizes actual and expected benefit payments and contributions for our other pension and post-retirement plans: Year Ended June 30 (In millions) Expected 2025 2024 2023 Non-qualified domestic noncontributory pension plan benefit payments $ 28 $ 8 $ 14 International defined benefit pension plan contributions $ 29 $ 24 $ 35 Post-retirement plan benefit payments $ 13 $ 13 $ 13 Commitments and Contingencies For a discussion of our contingencies, see to Item 8.
The following table summarizes actual and expected benefit payments and contributions for our other pension and post-retirement plans: Year Ended June 30, (In millions) Expected 2026 2025 2024 Non-qualified domestic noncontributory pension plan benefit payments $ 30 $ 9 $ 8 International defined benefit pension plan contributions $ 32 $ 35 $ 24 Post-retirement plan benefit payments $ 9 $ 14 $ 13 Commitments and Contingencies For a discussion of our commitments and contingencies, see Item 8.
Market Risk We address certain financial exposures through a controlled program of market risk management that includes the use of foreign currency forward contracts to reduce the effects of fluctuating foreign currency exchange rates and to mitigate the change in fair value of specific assets and liabilities on the balance sheet.
Market Risk We address certain financial exposures through a controlled program of market risk management that includes the use of foreign currency forward contracts to reduce the effects of fluctuating foreign currency exchange rates and to mitigate the change in fair value of specific assets and liabilities on the balance sheet, anticipated transactions and receivables and payables and the net investment in certain foreign operations.
The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of stock-based compensation, the taxation of foreign income and income tax reserve adjustments, which represent changes in our net liability for unrecognized tax benefits including tax settlements and lapses of the applicable statutes of limitations.
The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of stock-based compensation, the taxation of foreign income and income tax reserve adjustments, which represent changes in our net liability for unrecognized tax benefits including tax settlements and lapses of the applicable statutes of limitations, as well as changes to valuation allowance based on our assessment of the realizability of deferred tax assets.
In addition, we enter into interest rate derivatives to manage the effects of interest rate movements on our aggregate liability portfolio, including future debt issuances.
In addition, we enter into interest rate derivatives to manage the effects of interest rate movements on our funded indebtedness, including future debt issuances.
Fiscal 2024 as Compared with Fiscal 2023 NET SALES Year Ended June 30 ($ in millions) 2024 2023 As Reported: Net sales $ 15,608 $ 15,910 $ Change from prior year (302) (1,827) % Change from prior year (2) % (10) % Non-GAAP Financial Measure (1) : % Change from prior year in constant currency (1) % (7) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Fiscal 2025 as Compared with Fiscal 2024 NET SALES Year Ended June 30, ($ in millions) 2025 2024 As Reported: Net sales $ 14,326 $ 15,608 $ Change from prior year (1,282) (302) % Change from prior year (8) % (2) % Non-GAAP Financial Measure (1) : % Change from prior year in constant currency (8) % (1) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
As of August 12, 2024, our long-term debt is rated A with a negative outlook by Standard & Poor’s and A1 with a negative outlook by Moody’s. Debt and Access to Liquidity Total debt as a percent of total capitalization was 59% at June 30, 2024 and 2023.
As of August 13, 2025, our long-term debt is rated A- with a negative outlook by Standard & Poor’s and A3 with a negative outlook by Moody’s. Debt and Access to Liquidity Total debt as a percent of total capitalization was 65% and 59% at June 30, 2025 and 2024, respectively.
At June 30, 2024, we had cash and cash equivalents of $3,395 million compared with $4,029 million at June 30, 2023. Our cash and cash equivalents are maintained at a number of financial institutions.
At June 30, 2025, we had cash and cash equivalents of $2,921 million compared with $3,395 million at June 30, 2024. Our cash and cash equivalents are maintained at a number of financial institutions.
The Tax Cuts and Jobs Act (the "TCJA") resulted in the Transition Tax on unrepatriated earnings of our foreign subsidiaries and changed the tax law in ways that present opportunities to repatriate cash without additional U.S. federal income tax.
The Tax Cuts and Jobs Act resulted in the Transition Tax on unrepatriated earnings of our foreign subsidiaries and changed the tax law in ways that present opportunities to repatriate cash without additional U.S. federal income tax. We continue to analyze the indefinite reinvestment assertion on our remaining applicable foreign earnings.
(25) % (52) % (1) See “Reconciliations of Non-GAAP Financial Measures” below for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
(42) % (25) % (1) See “Reconciliations of Non-GAAP Financial Measures” on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
The following tables present Net sales, Operating income and Diluted net earnings per common share adjusted to exclude the impact of charges associated with restructuring and other activities; goodwill and other intangible asset impairments; the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax; and the effects of foreign currency translation.
The following tables present Net sales, Operating (loss) income, Provision for income taxes and Diluted net (loss) earnings per common share adjusted to exclude the impact of charges associated with restructuring and other activities; goodwill and other intangible asset impairments; U.S. deferred tax asset valuation allowance adjustment; talcum litigation settlement agreements; the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax; and the effects of foreign currency translation.
Reported skin care net sales decreased 4% in fiscal 2024, driven by the decrease from volume of 11% and the unfavorable impact from foreign currency translation of 1%. Partially offsetting these decreases was an increase from pricing of 8%, due to the favorable impact from strategic pricing actions and changes in mix.
Reported net sales in The Americas decreased 4% in fiscal 2025, driven by the decrease from volume of 8% and the unfavorable impact from foreign currency translation of 1%. These decreases were partially offset by an increase from pricing of 6%, due to the favorable impact of strategic pricing actions and changes in mix.
We also enter into cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt.
We also enter into cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt and to hedge a portion of the net investment in certain foreign operations.
We consider accounting estimates to be critical if the accounting estimate both (i) involves a significant level of estimation uncertainty, and (ii) has had or is reasonably likely to have a material impact on the Company's financial condition or results of operations. Our critical accounting policies relate to Goodwill and Other Indefinite-lived Intangible Assets - Impairment Assessment and Income Taxes.
We consider accounting estimates to be critical if the accounting estimate both (i) involves a significant level of estimation uncertainty, and (ii) has had or is reasonably likely to have a material impact on the Company's financial condition or results of operations.
This decrease was partially offset by an increase from pricing of 9%, due to the favorable impact from strategic pricing actions and changes in mix, and the favorable impact from foreign currency translation of 1%.
Partially offsetting this decrease was an increase from pricing of 3%, due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Year Ended June 30 ($ in millions, except per share data) 2024 2023 As Reported: Net earnings attributable to The Estée Lauder Companies Inc. $ 390 $ 1,006 $ Change from prior year (616) (1,384) % Change from prior year (61) % (58) % Diluted net earnings per common share $ 1.08 $ 2.79 % Change from prior year (61) % (57) % Non-GAAP Financial Measure (1) : % Change in diluted net earnings per common share from the prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill and other intangible asset impairments and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax.
Year Ended June 30, ($ in millions, except per share data) 2025 2024 As Reported: Net (loss) earnings attributable to The Estée Lauder Companies Inc. $ (1,133) $ 390 $ Change from prior year (1,523) (616) % Change from prior year (100+)% (61) % Diluted net (loss) earnings per common share $ (3.15) $ 1.08 % Change from prior year (100+)% (61) % Non-GAAP Financial Measure (1) : % Change in diluted net (loss) earnings per common share from the prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill and other intangible asset impairments, U.S. deferred tax asset valuation allowance adjustment, talcum litigation settlement agreements and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax.
Year Ended June 30 ($ in millions) 2024 2023 Earnings before income taxes: $ 772 $ 1,397 As Reported: Effective rate for income taxes 47.0 % 27.7 % Basis-point change from prior year 1,930 700 Non-GAAP Financial Measure (1) : Effective rate for income taxes 31.0 % 26.5 % (1) Excludes the net impact on the effective tax rates of charges associated with restructuring and other activities, goodwill and other intangible asset impairments and changes in the fair value of DECIEM acquisition-related stock options inclusive of payroll tax.
Year Ended June 30, ($ in millions) 2025 2024 (Loss) earnings before income taxes: $ (1,040) $ 772 As Reported: Effective rate for income taxes (8.9) % 47.0 % Basis-point change from prior year (5,590) 1,930 Non-GAAP Financial Measure (1) : Effective rate for income taxes 38.8 % 31.0 % (1) Excludes the net impact on the effective tax rates of charges associated with restructuring and other activities, goodwill and other intangible asset impairments, U.S. deferred tax asset valuation allowance adjustment and talcum litigation settlement agreements for fiscal 2025 and charges associated with restructuring and other activities, goodwill and other intangible asset impairments and changes in the fair value of DECIEM acquisition-related stock options inclusive of payroll tax for fiscal 2024.
For fiscal 2024 and 2023, we elected to perform the qualitative assessment for the goodwill in certain of our reporting units and other indefinite-lived intangible assets. This qualitative assessment included the review of certain macroeconomic factors and entity-specific qualitative factors to determine if it was more-likely-than-not that the fair values of its reporting units were below carrying value.
This qualitative assessment included the review of certain macroeconomic factors and entity-specific qualitative factors to determine if it was more-likely-than-not that the estimated fair values of the reporting units and other indefinite-lived intangible assets were below their carrying values.
In addition to these macroeconomic factors, among other things, we considered the reporting units’ current results and forecasts, any changes in the nature of the business, any significant legal, regulatory, contractual, political or other business climate factors, changes in the industry/competitive environment, changes in the composition or carrying amount of net assets and its intention to sell or dispose of a reporting unit or cease the use of a trademark.
In addition to these macroeconomic factors, among other things, we considered the reporting units’ current results and forecasts, any changes in the nature of the business, any significant legal, regulatory, contractual, political or other business climate factors, changes in the industry/competitive environment, changes in the composition or carrying amount of net assets and the Company's intention to sell or dispose of a reporting unit or cease the use of a trademark. 54 Table of Contents For fiscal 2025 and 2024, a quantitative assessment was performed for the goodwill in certain of our reporting units and other indefinite-lived intangible assets.
Reported makeup net sales decreased 1% in fiscal 2024, driven by the decrease from volume of 6%, partially offset by an increase from pricing of 5%, due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Reported skin care net sales decreased 12% in fiscal 2025, driven by the decrease from volume of 13%. Partially offsetting this decrease was an increase from pricing of 1%, due to the favorable impact from strategic pricing actions, partially offset by changes in mix.
Partially offsetting these decreases was an increase from pricing of 8%, due to the favorable impact from strategic pricing actions and changes in mix. GROSS MARGIN Gross margin in fiscal 2024 increased to 71.7% as compared with 71.3% in fiscal 2023. Fiscal 2024 vs.
Partially offsetting this decrease was an increase from pricing of 5%, due to the favorable impact from strategic pricing actions and changes in mix. 39 Table of Contents GROSS MARGIN Gross margin in fiscal 2025 increased to 74.0% as compared with 71.7% in fiscal 2024. Fiscal 2025 vs.
The decrease in operating income from Clinique was primarily driven by a decrease in net sales. Operating income from Estée Lauder decreased, primarily driven by a decrease in net sales, partially offset by disciplined advertising and promotional expense management.
Operating income from M·A·C decreased, primarily driven by a decrease in net sales, partially offset by lower cost of sales and disciplined advertising and promotional expense management.
Reported hair care net sales decreased 4% in fiscal 2024, driven by the decrease from volume of 11%, partially offset by an increase from pricing of 7%, due to the favorable impact from strategic pricing actions and changes in mix.
Reported fragrance net sales increased slightly in fiscal 2025, driven by an increase from pricing of 6%, due to the favorable impact from strategic pricing actions and changes in mix, largely offset by the decrease from volume of 6%.
Accordingly, the following discussions of Operating income by Product Categories and Geographic Regions exclude the fiscal 2024 and 2023 impact of charges associated with restructuring and other activities of $124 million, or approximately 1% of net sales and $85 million, or approximately 1% of net sales, respectively.
Accordingly, the following discussions of Net sales by Product Categories and Geographic Regions exclude the fiscal 2025 and fiscal 2024 impacts of returns/(return adjustments) associated with restructuring and other activities of approximately $(3) million and $1 million, respectively.
OPERATING RESULTS Year Ended June 30 ($ in millions) 2024 2023 As Reported: Operating income $ 970 $ 1,509 $ Change from prior year (539) (1,661) % Change from prior year (36) % (52) % Operating Margin 6.2 % 9.5 % Non-GAAP Financial Measure (1) : % Change in operating income from the prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill and other intangible asset impairments and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax (13) % (48) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Additionally, general and administrative expenses declined reflecting benefits from the above noted disciplined expense management, however also reflected the year-over-year unfavorable impact of a change in policy related to local government subsidies in China. 41 Table of Contents OPERATING RESULTS Year Ended June 30, ($ in millions) 2025 2024 As Reported: Operating (loss) income $ (785) $ 970 $ Change from prior year (1,755) (539) % Change from prior year (100+)% (36) % Operating Margin (5.5) % 6.2 % Non-GAAP Financial Measure (1) : % Change in operating (loss) income from the prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill and other intangible asset impairments, talcum litigation settlement agreements and the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax (28) % (13) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
GAAP measures. Reported skin care net sales decreased in fiscal 2024, reflecting lower net sales from Estée Lauder, Clinique and Dr.Jart+, combined, of approximately $514 million, primarily driven by declines in mainland China and in our Asia travel retail business. In mainland China, net sales declined, primarily driven by ongoing softness in overall prestige beauty.
GAAP measures. Skin Care Reported skin care net sales decreased $946 million, or 12%, in fiscal 2025, reflecting lower net sales from Estée Lauder and La Mer, combined, of approximately $829 million, primarily driven by declines in our Asia travel retail business.
We use a single quantitative step when determining the subsequent measurement of goodwill by comparing the fair value of a reporting unit with its carrying amount and recording an impairment charge for the amount that the carrying amount exceeds the fair value, up to the total amount of goodwill allocated to that reporting unit.
The quantitative impairment test for goodwill encompasses calculating the estimated fair value of a reporting unit and comparing the estimated fair value to its carrying value. If the carrying value exceeds the estimated fair value, an impairment charge is recorded, up to the total amount of goodwill allocated to that reporting unit.
Our management has discussed the selection of critical accounting policies and the effect of estimates with the Audit Committee of our Board of Directors. Goodwill and Other Indefinite-lived Intangible Assets – Impairment Assessment Goodwill is calculated as the excess of the cost of purchased businesses over the fair value of their underlying net assets.
Our critical accounting policies relate to Goodwill and Other Indefinite-lived Intangible Assets – Impairment Assessment, Dr.Jart+ Other Intangible Asset – Impairment and Income Taxes. Our management has discussed the selection of critical accounting policies and the effect of estimates with the Audit Committee of our Board of Directors.
GAAP measures. Reported net sales decreased in fiscal 2024, primarily reflecting a decrease in skin care, and to a lesser extent, decreases in makeup and hair care, partially offset by an increase in fragrance.
GAAP measures. Reported net sales decreased in fiscal 2025, primarily reflecting a decrease in skin care, and to a lesser extent, decreases in makeup and hair care. The decrease in skin care net sales was primarily driven by lower net sales from Estée Lauder and La Mer.
The increase was primarily attributable to the impact of nondeductible goodwill impairment charges associated with the our Dr.Jart+ reporting unit of approximately 790 basis points, as well as a higher effective tax rate on the our foreign operations of approximately 730 basis points, due to the our geographical mix of earnings for fiscal 2024, and an unfavorable impact associated with previously issued stock-based compensation of approximately 380 basis points.
The decrease was primarily attributable to the higher effective tax rate on income from our foreign operations of approximately 2,630 basis points, due to our geographical mix of earnings for fiscal 2025, establishment of a valuation allowance against general foreign tax credit and research and development tax credit carryforwards of approximately 1,651 basis points, the impact of nondeductible goodwill impairment charges associated with the Too Faced reporting unit of approximately 800 basis points and the unfavorable impact associated with previously issued stock-based compensation of approximately 640 basis points.
Fiscal 2023 Favorable (Unfavorable) Basis Points As Reported: Mix of business 155 Obsolescence charges 45 Manufacturing costs and other (95) Foreign exchange transactions (75) Returns and charges associated with restructuring and other activities 10 As Reported Gross Margin Basis Point Variance 40 Non-GAAP Financial Measure Adjustments: Returns and charges associated with restructuring and other activities (10) Non-GAAP Gross Margin Basis Point Variance 30 As reported, the increase in gross margin for fiscal 2024 reflected a favorable impact from our mix of business, reflecting the benefits of strategic pricing actions and changes in brand mix.
Fiscal 2024 Favorable (Unfavorable) Basis Points As Reported: Mix of business (30) Obsolescence charges 125 Manufacturing costs and other 145 Foreign exchange transactions (10) Returns and charges associated with restructuring and other activities — As Reported Gross Margin Basis Point Variance 230 Non-GAAP Financial Measure Adjustments: Returns and charges associated with restructuring and other activities — Non-GAAP Gross Margin Basis Point Variance 230 The increase in gross margin in fiscal 2025 includes net benefits from the PRGP which drove overall favorability year-over-year, including the favorability within manufacturing costs and other and obsolescence charges.
Also contributing to the increase in interest expense was higher interest rates compared to the prior year. Interest income and investment income, net increased, primarily reflecting higher interest rates compared to the prior year. 44 Table of Contents PROVISION FOR INCOME TAXES The provision for income taxes represents U.S. federal, foreign, state and local income taxes.
Interest income and investment income, net decreased in fiscal 2025, primarily reflecting a lower average cash balance and lower interest rates compared to the prior year. PROVISION FOR INCOME TAXES The provision for income taxes represents U.S. federal, foreign, state and local income taxes.
The increase in operating income from La Mer was primarily driven by an increase in net sales and a decrease in cost of sales, partially offset by an increase in advertising and promotional expenses to support growth of the business as well as higher selling costs due to an increase in demonstration expenses compared to the prior year and targeted expanded consumer reach.
The decrease in operating income from Jo Malone London was primarily driven by higher selling expenses, including higher staffing costs to support key campaigns and targeted expanded consumer reach, higher advertising and promotional activities to support key campaigns and higher store operating costs to support targeted expanded consumer reach, partially offset by an increase in net sales.
The reported operating margin for fiscal 2024 decreased from the prior year, primarily driven by the decreases in net sales and operating expense margin, partially offset by an increase in gross margin, as discussed above. 40 Table of Contents Charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
Partially offsetting this decrease was an increase from pricing of 2%, due to the favorable impact from strategic pricing actions, partially offset by changes in mix. 36 Table of Contents Returns associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed a Company-wide initiative to redesign, resize and reorganize select areas of the business.
GAAP measures. Reported operating income decreased in Asia/Pacific in fiscal 2024, primarily driven by Korea, led by the Dr.Jart+ travel retail business in Korea, and lower results in mainland China, combined, of approximately $562 million.
GAAP measures. The decrease in reported operating results in fiscal 2025 was primarily driven by lower operating results in North America, and to a lesser extent, a decrease in operating income in mainland China and in our travel retail business, combined, of approximately $1,273 million.
The change in net cash flows provided by (used for) financing activities primarily reflected an unfavorable impact from the issuance and redemption of long-term debt compared to the prior year, repayments of commercial paper during fiscal 2024 as compared to the proceeds from the issuance of commercial paper in the prior year, and payments associated with the purchase of the remaining interest in DECIEM during the fiscal 2024 fourth quarter, partially offset by lower treasury stock repurchases compared to the prior year.
The change in net cash flows used for investing activities was primarily driven by a favorable year-over-year impact from capital expenditure payments made relating to the manufacturing facility in Japan, near Tokyo, in the prior year. 51 Table of Contents The change in net cash flows used for financing activities primarily reflected the favorable year-over-year impacts of repayments of commercial paper in the prior year, payments associated with the purchase of the remaining interest in DECIEM during fiscal 2024 and a decrease in dividends paid to stockholders in the current year, partially offset by the unfavorable year-over-year impact of the repayment of long-term debt in the current year and issuance of long-term debt in the prior year.
To determine the estimated fair value of the reporting units, we used an equal weighting of the income and market approaches.
We engaged third-party valuation specialists and used industry accepted valuation models and criteria that were reviewed and approved by various levels of management. To determine the estimated fair value of the reporting units, we used an equal weighting of the income and market approaches.
GAAP measures. 38 Table of Contents Reported net sales decreased in Asia/Pacific in fiscal 2024, reflecting lower net sales from mainland China, and to a lesser extent Korea, combined, of approximately $401 million. The decrease in net sales from mainland China was primarily driven by ongoing softness in overall prestige beauty.
GAAP measures. 38 Table of Contents Reported net sales decreased in fiscal 2025 across all geographic regions, primarily driven by lower net sales in our travel retail business, and to a lesser extent, in mainland China, North America and Korea, combined, of approximately $1,150 million.
Operating income from Estée Lauder and Clinique decreased, primarily driven by decreases in net sales, partially offset by disciplined advertising and promotional expense management and lower shipping expenses due to the decreases in net sales.
The decrease in operating income from Estée Lauder was primarily driven by lower net sales and an increase in advertising and promotional activities to support new product launches, partially offset by lower cost of sales.
The decrease in operating income in mainland China was primarily driven by a decrease in net sales, partially offset by disciplined advertising and promotional expense management.
The decrease in operating income from La Mer was primarily driven by a decrease in net sales, partially offset by lower cost of sales.
Reported net sales decreased 2% in fiscal 2024, driven by the decrease from volume of 8% and the unfavorable impact from foreign currency translation of 1%. Partially offsetting these decreases was an increase from pricing of 7%, due to the favorable impact from strategic pricing actions and changes in mix.
Reported hair care net sales decreased 10% in fiscal 2025, driven by the decrease from volume of 10%. The impact of pricing was flat year-over-year, due to the favorable impact of strategic pricing actions offset by changes in mix.
Fiscal 2023 Favorable (Unfavorable) Basis Points As Reported: General and administrative expenses (10) Advertising, merchandising, sampling and product development (20) Selling (50) Shipping 20 Store operating costs (60) Stock-based compensation (40) Foreign exchange transactions 30 Charges associated with restructuring and other activities (50) Goodwill and other intangible asset impairments (180) As Reported Operating Expense Margin Basis Point Variance (360) Non-GAAP Financial Measure Adjustments: Impact of restructuring and other activities 20 Goodwill and other intangible asset impairments 180 Non-GAAP Operating Expense Margin Basis Point Variance (160) Higher store operating costs and selling expenses in fiscal 2024 reflect our continued investments in our business including through targeted expanded consumer reach and increased demonstration expenses.
Fiscal 2024 Favorable (Unfavorable) Basis Points As Reported: General and administrative expenses (90) Advertising, marketing, promotion and product development (1) (180) Selling (140) Shipping 10 Store operating costs (50) Stock-based compensation — Foreign exchange transactions — Charges associated with restructuring and other activities (260) Goodwill and other intangible asset impairments (590) Talcum litigation settlement agreements (110) Changes in fair value of DECIEM acquisition-related stock options 10 As Reported Operating Expense Margin Basis Point Variance (1,400) Non-GAAP Financial Measure Adjustments: Impact of restructuring and other activities 260 Goodwill and other intangible asset impairments 590 Talcum litigation settlement agreements 110 Changes in fair value of DECIEM acquisition-related stock options (10) Non-GAAP Operating Expense Margin Basis Point Variance (450) (1) Referred to as "advertising and promotional" within the Product Category and Geographic Region Operating Results disclosures below.
GAAP measures. 35 Table of Contents Reported makeup net sales decreased slightly in fiscal 2024, reflecting lower net sales primarily from M·A·C, and to a lesser extent, TOM FORD and La Mer, combined, of approximately $127 million.
Makeup Reported makeup net sales decreased $265 million, or 6%, in fiscal 2025, reflecting lower net sales primarily from M·A·C, and to a lesser extent, Estée Lauder, Too Faced and Bobbi Brown, combined, of approximately $241 million.
Net sales from Le Labo increased in every geographic region, led by Asia/Pacific and primarily reflected growth of hero products, including the successful City Exclusive collection, targeted expanded consumer reach, including the brand's launch in mainland China during the fiscal 2023 fourth quarter, and new product launches.
Net sales from Le Labo increased, reflecting growth from hero products, including growth through targeted expanded consumer reach, and new product launches. The increase in net sales from KILIAN PARIS primarily reflected the success of new product launches.
The net sales decrease in Asia/Pacific included approximately $155 million of unfavorable foreign currency translation. Reported net sales in Asia/Pacific decreased 6% in fiscal 2024, driven by the decrease from volume of 11% and the unfavorable impact from foreign currency translation of 3%.
Reported net sales in Asia/Pacific decreased 7% in fiscal 2025, driven by the decrease from volume of 12%.
Accordingly, the following discussions of Net sales by Product Categories and Geographic Regions exclude the fiscal 2024 and fiscal 2023 impacts of returns associated with restructuring and other activities of approximately $1 million and $27 million, respectively. 34 Table of Contents Product Categories Skin Care Year Ended June 30 ($ in millions) 2024 2023 As Reported: Net sales $ 7,908 $ 8,249 $ Change from prior year (341) (1,653) % Change from prior year (4) % (17) % Non-GAAP Financial Measure (1) : % Change from prior year in constant currency (3) % (13) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Product Categories Reported net sales for our product categories for the years ended June 30, 2025 and 2024 were as follows: Year Ended June 30, ($ in millions) 2025 2024 $ Change % Change % Change in Constant Currency (1) Skin Care $ 6,962 $ 7,908 $ (946) (12) % (12) % Makeup 4,205 4,470 (265) (6) (5) Fragrance 2,491 2,487 4 — — Hair Care 565 629 (64) (10) (10) Other 100 115 (15) (13) (13) 14,323 15,609 (1,286) (8) (8) Returns associated with restructuring and other activities 3 (1) 4 100+ 100+ Net sales $ 14,326 $ 15,608 $ (1,282) (8) % (8) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Asia/Pacific Year Ended June 30 ($ in millions) 2024 2023 As Reported: Net sales $ 4,888 $ 5,194 $ Change from prior year (306) (243) % Change from prior year (6) % (4) % Non-GAAP Financial Measure (1) : % Change from prior year in constant currency (3) % 4 % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Geographic Regions Reported net sales by geographic region for the years ended June 30, 2025 and 2024 were as follows: Year Ended June 30, ($ in millions) 2025 2024 $ Change % Change % Change in Constant Currency (1) The Americas $ 4,411 $ 4,581 $ (170) (4) % (3) % Europe, the Middle East & Africa 5,375 6,140 (765) (12) (13) Asia/Pacific 4,537 4,888 (351) (7) (7) 14,323 15,609 (1,286) (8) (8) Returns associated with restructuring and other activities 3 (1) 4 100+ 100+ Net sales $ 14,326 $ 15,608 $ (1,282) (8) % (8) % (1) See “ Reconciliations of Non-GAAP Financial Measures” beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
The decrease in skin care net sales was primarily driven by lower net sales from Estée Lauder, Clinique and Dr.Jart+, partially offset by higher net sales from La Mer and The Ordinary.
The decrease in net sales from Estée Lauder was primarily driven by lower net sales from the Estée Lauder Beautiful and Estée Lauder Pleasures franchises. Net sales from Clinique decreased, primarily driven by lower net sales from the Clinique Happy franchise line of products.
Europe, the Middle East & Africa Year Ended June 30 ($ in millions) 2024 2023 As Reported: Operating income $ 836 $ 843 $ Change from prior year (7) (517) % Change from prior year (1) % (38) % Non-GAAP Financial Measure (1) : % Change in operating income from the prior year adjusting for the impact of the change in fair value of DECIEM acquisition-related stock options inclusive of payroll tax — % (38) % (1) See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Geographic Regions Year Ended June 30, ($ in millions) 2025 2024 $ Change % Change (As Reported) % Change (Non-GAAP) (1) Non-GAAP Financial Measure (1) The Americas $ (918) $ 34 $ (952) (100+)% 100+% Adjusted for the impact of goodwill and other intangible asset impairments, talcum litigation settlement agreements and change in fair value of DECIEM acquisition-related stock options Europe, the Middle East & Africa 610 836 (226) (27) (28) Asia/Pacific 9 224 (215) (96) (45) Adjusted for the impact of goodwill and other intangible asset impairments (299) 1,094 (1,393) (100+) (28) Charges associated with restructuring and other activities (486) (124) (362) (100+) (100+) Operating (loss) income $ (785) $ 970 $ (1,755) (100+)% (100+)% (1) See “Reconciliations of Non-GAAP Financial Measures” beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S.
Net sales from TOM FORD decreased, primarily driven by lower net sales from the lip subcategory.
Net sales from Too Faced decreased, driven by North America, primarily reflecting lower net sales in the lip and eye subcategories. Bobbi Brown net sales decreased, primarily driven by lower net sales in the face subcategory.
Reported net sales in The Americas increased 1% in fiscal 2024, driven by an increase from pricing of 2% due to the favorable impact of strategic pricing actions, partially offset by changes in mix, and the impact from the royalty revenue from the fiscal 2023 fourth quarter acquisition of the TOM FORD brand of 1%.
Reported net sales in Europe, the Middle East & Africa decreased 12% in fiscal 2025, driven by the decrease from volume of 10% and a decrease from pricing of 3%. The decrease from pricing is due to changes in mix, partially offset by the favorable impact from strategic pricing actions.
GAAP measures. Reported skin care operating income decreased in fiscal 2024, reflecting lower operating results from Dr.Jart+, Estée Lauder and Clinique, combined, of approximately $580 million. The decrease in operating income from Dr.Jart+ was primarily driven by the unfavorable year-over-year impact of goodwill and other intangible asset impairments of $371 million as well as a decrease in net sales.
The reported operating margin for fiscal 2025 decreased from the prior year, driven by the decrease in net sales as well as an increase in our operating expense margin, reflecting the unfavorable year-over-year impact of goodwill and other intangible asset impairments relating to TOM FORD, Dr.Jart+ and Too Faced, combined, of $1,286 million in fiscal 2025 compared with goodwill and other intangible asset impairments relating to Dr.Jart+ of $471 million in fiscal 2024, partially offset by an increase in gross margin, as discussed above.
INTEREST AND INVESTMENT INCOME Year Ended June 30 (In millions) 2024 2023 Interest expense $ 378 $ 255 Interest income and investment income, net $ 167 $ 131 Interest expense increased for fiscal 2024, primarily reflecting a higher debt balance, due in part to the financing of our acquisition of the TOM FORD brand, including the issuance of Senior Notes in May 2023, as well as the issuance of Senior Notes in February 2024.
INTEREST AND INVESTMENT INCOME Year Ended June 30, (In millions) 2025 2024 Interest expense $ 357 $ 378 Interest income and investment income, net $ 114 $ 167 Interest expense decreased in fiscal 2025, primarily reflecting a lower average debt balance compared to the prior year.
The significant assumptions used in this approach include revenue growth rates, terminal value, the weighted average cost of capital used to discount future cash flows and royalty rate. 52 Table of Contents For further discussion of the methods used and factors considered in our estimates as part of the impairment testing for Goodwill and Other Indefinite-lived Intangible Assets, see Item 8.
As a result of the estimated fair values, the impairment charge was allocated entirely to the Dr.Jart+ customer list intangible asset. For further discussion of the methods used and factors considered in our estimates as part of the impairment testing for goodwill and other indefinite-lived intangible assets and impairment of the Dr.Jart+ customer list intangible asset, see Item 8.
The decrease in operating income from TOM FORD was primarily driven by higher cost of sales, due in part to an increase in promotional items, higher selling expenses due to an increase in demonstration expenses compared to the prior year, higher advertising and promotional expenses and an increase in general and administrative expenses, as the brand continues to invest and support the growth of the business, partially offset by a decrease in royalty expense as a result of the fiscal 2023 fourth quarter acquisition of TOM FORD brand.
The decrease in operating results from TOM FORD was primarily driven by the fiscal 2025 other intangible asset impairment charge of $549 million, and to a lesser extent, a decline in net sales, as well as an increase in advertising and promotional activities and an increase in selling expenses to support sales, partially offset by lower cost of sales.
Other indefinite-lived intangible assets principally consist of trademarks. Goodwill and other indefinite-lived intangible assets are not amortized.
Goodwill and Other Indefinite-lived Intangible Assets – Impairment Assessment and Dr.Jart+ Other Intangible Asset – Impairment Goodwill is calculated as the excess of the cost of purchased businesses over the estimated fair value of their underlying net assets. Other indefinite-lived intangible assets principally consist of trademarks. Goodwill and other indefinite-lived intangible assets are not amortized.
GAAP measures. Reported fragrance net sales increased slightly in fiscal 2024, reflecting higher net sales from Le Labo and Jo Malone London, combined, of approximately $96 million.
Fragrance Reported fragrance net sales increased slightly in fiscal 2025, reflecting higher net sales from Le Labo and to a lesser extent, KILIAN PARIS combined, of approximately $87 million, largely offset by lower net sales from Estée Lauder, Clinique, and TOM FORD, combined, of approximately $82 million.